United States · FDA National Drug Code directory
Nelarabine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 25021-259_c956537f-71c0-44bc-a2e2-ab2adaa4f756
- Product NDC
- 25021-259
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Nelarabine
- Labeler
- Sagent Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240801
- Source listing expiry
- 20261231
Source-listed ingredients
- NELARABINE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (25021-259-50) / 50 mL in 1 VIAL · 25021-259-50
- 6 VIAL in 1 CARTON (25021-259-51) / 50 mL in 1 VIAL · 25021-259-51
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →